Sprint Bioscience is constantly looking for highly interesting starting points for preclinical drug development projects, primarily in the field of cancer. Through a collaboration with Dr Julian Walfridsson at Karolinska Institutet, the company will identify new target proteins suitable for the treatment of blood cancer. The project has now been rewarded with a 2.5 MSEK research grant from the Swedish Foundation for Strategic Research.
Read the full article at biostock.se:
https://www.biostock.se/en/2021/10/sprint-bioscience-gets-research-grant/
This is a press release from BioStock – Connecting Innovation & Capital. https://www.biostock.se
